Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Clay Faquin, M.D., Ph.D.


This page shows the publications co-authored by William Faquin and Zachary Peacock.
Connection Strength

  1. What Is Important for Confirming Negative Margins When Resecting Mandibular Ameloblastomas? J Oral Maxillofac Surg. 2017 Jun; 75(6):1185-1190.
    View in: PubMed
    Score: 0.687
  2. Genetic Analysis of Giant Cell Lesions of the Maxillofacial and Axial/Appendicular Skeletons. J Oral Maxillofac Surg. 2017 Feb; 75(2):298-308.
    View in: PubMed
    Score: 0.168
  3. Bilateral Continuous Automated Distraction Osteogenesis: Proof of Principle. J Craniofac Surg. 2015 Nov; 26(8):2320-4.
    View in: PubMed
    Score: 0.160
  4. Skeletal and soft tissue response to automated, continuous, curvilinear distraction osteogenesis. J Oral Maxillofac Surg. 2014 Sep; 72(9):1773-87.
    View in: PubMed
    Score: 0.141
  5. Do histologic criteria predict biologic behavior of giant cell lesions? J Oral Maxillofac Surg. 2012 Nov; 70(11):2573-80.
    View in: PubMed
    Score: 0.124
  6. Accessory mandibular condyle at the coronoid process. J Craniofac Surg. 2011 Nov; 22(6):2168-71.
    View in: PubMed
    Score: 0.121
  7. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern. Am J Surg Pathol. 2019 06; 43(6):819-826.
    View in: PubMed
    Score: 0.051
  8. Unicystic Ameloblastoma Revisited: Comparison of Massachusetts General Hospital Outcomes With Original Robinson and Martinez Report. J Oral Maxillofac Surg. 2017 Nov; 75(11):2369-2378.
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.